Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT
Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT
Recruiting · NCT07498517 · Registry updated 2026-08-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT | Embolism and Thrombosis, cardiovascular disorder, thrombotic disease, vascular disorder | Recruiting | Phase 2 | 2026-08-31 | NCT07498517 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 791 |
| OHSU Knight Cancer Institute | 61 |
| Oregon Health and Science University | 244 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| OHSU Knight Cancer Institute | Portland | United States | 69 |